266 related articles for article (PubMed ID: 2931492)
1. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
Bryckaert MC; Pietu G; Ruan C; Tobelem G; Girma JP; Meyer D; Larrieu MJ; Caen JP
J Lab Clin Med; 1985 Oct; 106(4):393-400. PubMed ID: 2931492
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
3. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
Sakariassen KS; Nieuwenhuis HK; Sixma JJ
Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
[TBL] [Abstract][Full Text] [Related]
6. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
7. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
8. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
Niiya K; Kubonishi I; Taguchi H; Miyoshi I
Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
10. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
11. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
12. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
[TBL] [Abstract][Full Text] [Related]
13. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
[TBL] [Abstract][Full Text] [Related]
14. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
15. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
[TBL] [Abstract][Full Text] [Related]
16. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder.
Miller JL; Castella A
Blood; 1982 Sep; 60(3):790-4. PubMed ID: 6286015
[TBL] [Abstract][Full Text] [Related]
17. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
19. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
